Novo Nordisk is leaving no stone unturned in its bid to maintain its leading position in weight-loss therapies, planning for the future with a wide-ranging, $2.1 billion deal with drug delivery ...

Propranolol is a prescription beta-blocker that has been on the market for decades and is now widely available as a generic.

Vivtex, cofounded by renowned MIT professor Robert Langer, stands to make as much as $2.1 billion if milestones are met.

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.

GMRx2 is an innovative single pill combination of three medicines designed to deliver the blood pressure-lowering benefits of triple combination ...

Kenya takes a massive leap in HIV prevention, here is everything you need to know about the Lenacapavir rollout.

New discoveries of Stone Age symbols in Germany could push back the history of writing by over 30,000 years, potentially rewriting our understanding of early human communication.

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Demand for GLP-1 drugs continues to climb, boosted by a major price drop and the FDA’s approval of an oral Wegovy pill that has already generated more than 26,000 prescriptions in January.

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Blockbuster weight-loss drugs are transforming the way we treat obesity. But while costly injectable versions remain out of ...